相关实验视频

Updated: Jun 9, 2025

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Published on: March 17, 2023

质母细胞瘤中的线粒体DNA变化和当前的治疗点

Maher Kurdi¹, Ahmed Bamaga², Alaa Alkhotani³

¹Department of Pathology, Faculty of Medicine, King Abdulaziz University, 21911 Rabigh, Saudi Arabia.

Frontiers in bioscience (Landmark edition)

|October 30, 2024

概括

线粒体DNA (mtDNA) 突变对于质母细胞瘤的进展至关重要,但由于研究范围有限,经常被低估. 了解这些变化是开发针对脑瘤的新疗法策略的关键.

科学领域:

在瘤学瘤学.
遗传学遗传学是一个
细胞生物学细胞生物学

背景情况:

瘤细胞经历代谢重编程,往往导致线粒体功能障碍.
线粒体DNA (mtDNA) 突变与癌症进展有关,但对质母细胞瘤的研究有限.
之前的研究范围和敏感性有限,可能低估了mtDNA突变及其在质母细胞瘤中的异质体状态.

研究的目的:

审查线粒体DNA变化与质母细胞瘤之间的关联.
概述目前针对质母细胞瘤mtDNA变化的治疗策略.

主要方法:

文献综述侧重于质母细胞瘤中的线粒体DNA突变.
对mtDNA变异及其对质母细胞瘤进展的影响现有研究的分析.
检查针对癌症中线粒体功能障碍的治疗策略.

主要成果:

由mtDNA改变驱动的线粒体功能障碍是质母细胞瘤进展中的关键机制.
以前的研究可能低估了特定mtDNA突变和质母细胞瘤异质质体的流行率和影响.
线粒体功能的改变会影响生物能学,信号通路和氧化酸化效率.

结论:

线粒体功能障碍是质瘤发展的重要因素.
线粒体是克服化学抵抗和消除质母细胞瘤细胞的有希望的治疗点.
需要进一步的研究,以充分阐明mtDNA改变在质母细胞瘤中的作用,并开发向疗法.

关键词:

线粒体DNA突变的突变氧化化酸化质母细胞瘤治疗治疗治疗治疗治疗治疗

更多相关视频

MitoCeption: Transferring Isolated Human MSC Mitochondria to Glioblastoma Stem Cells

MitoCeption: Transferring Isolated Human MSC Mitochondria to Glioblastoma Stem Cells

Published on: February 22, 2017

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Electron Transport Chain: Complex I and II

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...